OTX-DED for the Short-term Treatment of the Symptoms of Dry Eye Disease (DED)

NCT05814757 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
100
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Ocular Therapeutix, Inc.